Nebivolol can be used for combination therapy in patients with autosomal dominant polycystic kidney disease. (4th March 2017)

Record Type:: Journal Article
Title:: Nebivolol can be used for combination therapy in patients with autosomal dominant polycystic kidney disease. (4th March 2017)
Main Title:: Nebivolol can be used for combination therapy in patients with autosomal dominant polycystic kidney disease
Authors:: Kocyigit, Ismail
Eroglu, Eray
Ecder, Tevfik
Abstract:
Is Part Of:: Expert opinion on pharmacotherapy. Volume 18:Number 4(2017)
Journal:: Expert opinion on pharmacotherapy
Issue:: Volume 18:Number 4(2017)
Issue Display:: Volume 18, Issue 4 (2017)
Year:: 2017
Volume:: 18
Issue:: 4
Issue Sort Value:: 2017-0018-0004-0000
Page Start:: 455
Page End:: 455
Publication Date:: 2017-03-04
Subjects:: Nebivolol -- polycystic kidney disease -- hypertension -- endothelial dysfunction
Chemotherapy -- Periodicals
615.5805
Journal URLs:: http://informahealthcare.com/ ↗
http://www.tandfonline.com/toc/ieop20/current ↗
http://informahealthcare.com ↗
http://titania.ashley-pub.com/vl=5663459/cl=52/nw=1/rpsv/journal/journal6_home.htm ↗
DOI:: 10.1080/14656566.2017.1293653 ↗
Languages:: English
ISSNs:: 1465-6566
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 3842.002956
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 5278.xml